ArticleBiofilm2026
Mapping the global landscape of biofilm-associated antimicrobial resistance (1992-2025).
Article in Biofilm, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Natural and Synthetic AMPs from Latin America across Diversity Engineering and Applications.ACS infectious diseases · 2026Review
- Antimicrobial resistance in dental unit waterlines: a scoping review of microbial diversity, resistance patterns, and knowledge gaps.Frontiers in oral health · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance (AMR) is a great global health threat, with biofilm formation recognized as a key microbial survival strategy that promotes persistence and recurrent infections. Despite growing mechanistic insights, research on biofilm-associated AMR ((biofilm-AMR)) remains fragmented, limiting the development of broadly effective interventions. To address this gap, we conducted a bibliometric analysis of 17,198 publications from the Web of Science Core Collection (retrieved November 4, 2025) using Bibliometrix-Biblioshiny, CiteSpace, and Excel. Publication output accelerated sharply after 2015, alongside diversification of research themes and increasing interdisciplinary integration. High-output countries and institutions, predominantly in Asia, Latin America, and the Middle East, emphasize natural products, nanomaterials, anti-quorum-sensing strategies, and plant-derived antimicrobials, reflecting application-oriented approaches. In contrast, high-impact contributors in North America and Europe focus on clinical microbiology, resistance mechanisms, pathogen genomics, and hospital infection control, highlighting translational relevance. Trend analyses reveal key topics including quorum sensing, persister-cell biology, multidrug-resistant pathogens, and innovative interventions such as phage therapy, antimicrobial peptides, CRISPR-based antimicrobials, and nanotechnology-enabled drug delivery. Emerging directions include environmental AMR, One Health perspectives, and computational modeling. Despite mechanistic and technological advances, translational barriers persist due to biofilm heterogeneity and model limitations. Promoting interdisciplinary collaboration that integrates basic research, clinical microbiology, materials science, and computational approaches will be essential to accelerate clinical translation and develop effective, globally relevant strategies against AMR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.